HALO logo
halo search icon
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp.
TNXP · NAS

Tonix Pharmaceuticals Holding Corp.

US$14.50

Price Arrow0.79 (5.76%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHALO Price Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Tonix Pharmaceuticals Holding Corp. Overview

TNXP Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About TNXP

icon

Telephone

1.862.799.8599

icon

Address

Suite 301, 200 Connell Drive, Berkeley Heights, NJ 07922

Description

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

TNXP Price Chart

Key Stats

Market Cap

US$218.55M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 11.6 - 69.97

Trade Value (12mth)

US$6,233,860.00

1 week

-12.9%

1 month

1.48%

YTD

-17.16%

1 year

-51.61%

All time high

26368000000.00

Key Fundamentals

EPS 3 yr Growth

-100.00%

EBITDA Margin

-944.40%

Operating Cashflow

-$100m

Free Cash Flow Return

-51.10%

ROIC

-63.50%

Interest Coverage

NaN

Quick Ratio

7.20

Other Data

Shares Outstanding (Fully Diluted)

14m

HALO Sector

Healthcare

Next Company Report Date

15-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

TNXP Announcements

Latest Announcements

DateAnnouncements
15 May 26
15 May 26
12 May 26
12 May 26
12 May 26

TNXP Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-21,908.48-17,659.80-14.57locklocklock
EPS (Fully Diluted)
$locklocklocklock-21,908.48-17,659.80-14.57locklocklock
Growth
%locklocklocklock66.519.499.9locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Tonix Pharmaceuticals Holding Corp. (TNXP:NAS)?
Halo FAQ
The current share price of Tonix Pharmaceuticals Holding Corp. (TNXP:NAS) is USD$14.50.
What is the 52-week high share price for Tonix Pharmaceuticals Holding Corp. (TNXP:NAS)?
Halo FAQ
The 52-week high share price for Tonix Pharmaceuticals Holding Corp. (TNXP:NAS) is USD$69.97.
What is the 52-week low share price for Tonix Pharmaceuticals Holding Corp. (TNXP:NAS)?
Halo FAQ
The 52-week low share price for Tonix Pharmaceuticals Holding Corp. (TNXP:NAS) is USD$11.60.
What is the dividend yield for Tonix Pharmaceuticals Holding Corp. (TNXP:NAS)?
Halo FAQ
Tonix Pharmaceuticals Holding Corp. (TNXP:NAS) does not pay a dividend.
What was Tonix Pharmaceuticals Holding Corp. (TNXP:NAS) last dividend payment?
Halo FAQ
Tonix Pharmaceuticals Holding Corp. (TNXP:NAS) does not pay a dividend.
What is the franking level for Tonix Pharmaceuticals Holding Corp. (TNXP:NAS)?
Halo FAQ
Tonix Pharmaceuticals Holding Corp. (TNXP:NAS) has a franking level of 0.00%.
In which sector is Tonix Pharmaceuticals Holding Corp. (TNXP:NAS) classified?
Halo FAQ
Tonix Pharmaceuticals Holding Corp. (TNXP:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.